Oligonucleotide therapeutics and their chemical modification strategies for clinical applications
Journal of Pharmaceutical Investigation · 2024-07 · 54 (4) · 415-433
DOI: 10.1007/s40005-024-00669-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Investigation, online erschienen am 29.02.2024. Verfasst von Hyunsook Kim und 5 weiteren Autor:innen. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 169 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, National Research Foundatio, National Research Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Korea Health Industry Development Institute
- National Research Foundatio
- National Research Foundation
Zitieren
APA
Kim, H., Kim, S., Lee, D., Lee, D., Yoon, J., & Lee, H. (2024). Oligonucleotide therapeutics and their chemical modification strategies for clinical applications. Journal of Pharmaceutical Investigation, 54(4), 415-433. https://doi.org/10.1007/s40005-024-00669-8
Vancouver
Kim H, Kim S, Lee D, Lee D, Yoon J, Lee H. Oligonucleotide therapeutics and their chemical modification strategies for clinical applications. Journal of Pharmaceutical Investigation. 2024;54(4):415-433. doi:10.1007/s40005-024-00669-8
BibTeX
@article{Kim2024,
author = {Kim, Hyunsook and Kim, Sujeong and Lee, Dayoung and Lee, Dahye and Yoon, Jiyeon and Lee, Hyukjin},
title = {Oligonucleotide therapeutics and their chemical modification strategies for clinical applications},
journal = {Journal of Pharmaceutical Investigation},
year = {2024},
volume = {54},
number = {4},
pages = {415--433},
doi = {10.1007/s40005-024-00669-8}
}
EUVIMED